Business Standard

Shanghvi says will participate in Suzlon Energy's Rs 1,200-cr rights issue

The rights issue will open on October 11, closing on October 20

Dilip Shanghvi
Premium

Dilip Shanghvi, the billionaire-promoter of Sun Pharmaceutical Industries

BS Reporter Mumbai
Suzlon Energy, on Friday said, that Dilip Shanghvi, the founder of Sun Pharmaceuticals, had conveyed to the promoters of the company his intentions to fully participate in the firm's upcoming Rs 1,200-cr rights issue. The rights issue will open on October 11, closing on October 20.

Shanghvi had bought a 23 per cent stake in Suzlon for Rs Rs 1,800 crore in 2015, helping the company to return to profitability after it became India’s largest convertible-bond defaulter in 2012.

In a letter to the Suzlon promoters, Shanghvi said that he would subscribe for additional shares as part of the rights

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in